Clinical Trial Detail

NCT ID NCT02644460
Title Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Cynthia Wetmore
Indications

brain cancer

rhabdoid cancer

Ewing sarcoma

osteosarcoma

malignant glioma

rhabdomyosarcoma

neuroblastoma

Advanced Solid Tumor

Therapies

Abemaciclib

Age Groups: adult child

No variant requirements are available.